Ontology highlight
ABSTRACT: Importance
The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroimaging sample of individuals at CHR to date, aims to discover robust neurobiological markers of psychosis risk.Objective
To investigate baseline structural neuroimaging differences between individuals at CHR and healthy controls as well as between participants at CHR who later developed a psychotic disorder (CHR-PS+) and those who did not (CHR-PS-).Design, setting, and participants
In this case-control study, baseline T1-weighted magnetic resonance imaging (MRI) data were pooled from 31 international sites participating in the ENIGMA Clinical High Risk for Psychosis Working Group. CHR status was assessed using the Comprehensive Assessment of At-Risk Mental States or Str
SUBMITTER: ENIGMA Clinical High Risk for Psychosis Working Group
PROVIDER: S-EPMC8100913 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature